Toronto Dominion Bank
ANIP icon

Toronto Dominion Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Toronto Dominion Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed – – 1317
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1405
2021
Q4 		$0 Buy
+1
New +$43 ﹤0.01% 1501
2014
Q1 		– Sell
-3
Closed – – 1047
2013
Q4 		$0 Hold
3
– – ﹤0.01% 1020
2013
Q3 		$0 Sell
3
-1
-25% -$7 ﹤0.01% 770
2013
Q2 		$0 Buy
+4
New +$28 ﹤0.01% 791

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

Toronto Dominion Bank's ANIP Position: Q2 2022 in Review

Toronto Dominion Bank sold out of ANI Pharmaceuticals (ANIP) in Q2 2022, closing a stake of 1 share.

Toronto Dominion Bank first reported a position in ANIP in Q2 2013 and held it in 5 quarters. The position peaked at $0 in Q1 2022. 120 funds tracked by Wall St. Rank hold ANIP as of Q2 2022.

  • Toronto Dominion Bank reported no remaining ANI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 1 ANI Pharmaceuticals share in Q2 2022.
  • Toronto Dominion Bank first reported a position in ANI Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Toronto Dominion Bank's ANI Pharmaceuticals position peaked at $0 in Q1 2022.
  • 120 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.